Back to results
US 5,326,783 AGranted
Cholesterol lowering compounds
AssigneeMerck & Co., Inc.
InventorsTesfaye Biftu, Chan-Hwa Kuo, Conrad Santini
Life of this patent
Estimating the term…
Abstract
This invention is directed to compounds of formula (I) which are novel C3- or C5-acyl sulfonamide, carboxamic acid or tetrazolyl analogs of the Zaragozic acids. These compounds inhibit the enzyme squalene synthase and are useful as cholesterol lowering agents. ##STR1##
Claims14
A compound of structural formula (I) ##STR10## wherein A is --C(O)--, --NR.sup.3 --C(O)--, or --OC(O)--;
- a is zero or 1;
- R.sup.1 is selected from the group consisting of:
- (1) C.sub.1-20 alkyl,
- (2) substituted C.sub.1-20 alkyl in which one or more substituents is selected from a group herein termed X.sup.3 wherein the group X.sup.3 consists of:
- (a) halogen,
- (b) hydroxy,
- (c) R.sup.3 R.sup.3 N--,
- (d) R.sup.2 O--,
- (e) R.sup.2 O--C(O)--,
- (f) R.sup.3 --C(O)--O--,
- (g) oxo,
- (h) C.sub.3-10 cycloalkyl,
- (i) aryl substituted with X and Y,
- (j) heteroaryl substituted with X and Y,
- (k) heterocycloalkyl,
- (l) aryl S(O).sub.n, wherein aryl is substituted with X and Y,
- (m) R.sup.3 --C(O)--NR.sup.3 --,
- (n) R.sup.3 R.sup.3 N--C(O)--,
- (o) --CO.sub.2 H,
- (p) --vinylidene,
- (q) R.sup.3 --C(O)--,
- (r) R.sup.2 O--C(O)--O--,
- (s) R.sup.3 R.sup.3 N--C(O)--O--, and
- (t) R.sup.2 O--C(O)--NR.sup.3 --;
- (3) C.sub.1-20 alkyl wherein one or more of the carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n --;
- (4) substituted C.sub.1-20 alkyl wherein one or more of the carbons is replaced by --NR.sup.3 --, --O-- or --S(O).sub.n -- and wherein one or more carbon substituents is selected from the group X.sup.3, defined above;
- (5) aryl substituted with X and Y;
- (6) heteroaryl substituted with X and Y;
- (7) C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds;
- (8) substituted C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (9) C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and one or more of the nonolefinic carbons is replaced by --NR.sup.3 --, --O-- or --S(O).sub.n --;
- (10) substituted C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and one or more of the nonolefinic carbons is replaced by --NR.sup.3 --, --O-- or --S(O).sub.n -- and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (11) C.sub.3-10 cycloalkyl;
- (12) substituted C.sub.3-10 cycloalkyl in which one or more of the substituents is selected from the group consisting of C.sub.1-10 alkyl--S(O).sub.n --, C.sub.1-10 alkyl, and the members of the group X.sup.3, defined above;
- each R.sup.2 is independently selected from:
- (1) C.sub.1-10 alkyl;
- (2) aryl substituted with X and Y;
- (3) arylC.sub.1-4 alkyl wherein aryl is substituted with X and Y;
- (4) heteroaryl wherein heteroaryl is substituted with X and Y;
- (5) heteroarylC.sub.1-4 alkyl-- wherein heteroaryl is substituted with X and Y;
- (6) heterocycloalkylC.sub.1-4 alkyl--;
- (7) C.sub.2-10 alkenyl;
- (8) arylC.sub.2-10 alkenyl wherein aryl is substituted with X and Y;
- and
- (9) C.sub.3-10 alkynyl;
- each R.sup.3 is independently selected from:
- (1) C.sub.1-10 alkyl;
- (2) aryl substituted with X and Y;
- (3) arylC.sub.1-4 alkyl wherein aryl is substituted with X and Y;
- (4) heteroaryl wherein heteroaryl is substituted with X and Y;
- (5) heteroarylC.sub.1-4 alkyl-- wherein heteroaryl is substituted with X and Y;
- (6) heterocycloalkylC.sub.1-4 alkyl--;
- (7) C.sub.2-10 alkenyl;
- (8) arylC.sub.2-10 alkenyl wherein aryl is substituted with X and Y;
- (9) C.sub.3-10 alkynyl;
- (10) hydrogen;
- and
- (11) C.sub.1-5 alkyl substituted with X.sup.1 ;
- R.sup.4 is selected from the group consisting of:
- (1) C.sub.1-20 alkyl;
- (2) substituted C.sub.1-20 alkyl in which one or more substituents is selected from the group X.sup.3, defined above;
- (3) C.sub.1-20 alkyl wherein one or more of the carbons is replaced by --NR.sub.3 --, --O--, or --S(O).sub.n --;
- (4) substituted C.sub.1-20 alkyl wherein one or more of the carbons is replaced by --NR.sup.3 --, --O-- or --S(O).sub.n -- and wherein one or more carbon substituents is selected from the group X.sup.3, defined above;
- (5) aryl substituted with X and Y;
- (6) heteroaryl substituted with X and Y;
- (7) C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds;
- (8) substituted C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (9) C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and one or more of the nonolefinic carbons is replaced by --NR.sup.3 --, --O-- or --S(O).sub.n --;
- (10) substituted C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and one or more of the nonolefinic carbons is replaced by --NR.sup.3 --, --O-- or --S(O).sub.n -- and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (11) C.sub.3-10 cycloalkyl;
- (12) substituted C.sub.3-10 cycloalkyl in which one or more of the substituents is selected from the group X.sup.3, defined above;
- and
- (13) hydrogen;
- R.sup.5 is selected from the group consisting of:
- (1) hydrogen;
- (2) C.sub.1-10 alkyl;
- (3) aryl substituted with X and Y;
- (4) arylC.sub.1-4 alkyl, wherein aryl is substituted with X and Y;
- (5) R.sup.2 O--C(O)--;
- (6) C.sub.3-10 cycloalkyl;
- (7) R.sup.3 --C(O)--;
- and
- (8) R.sup.3 R.sup.3 N--C(O)--;
- n is zero, 1 or 2;
- Z.sup.1 is selected from:
- (1) --CONHOH,
- (2) --CONHSO.sub.2 R, and
- (3) tetrazolyl;
- Z.sup.2 is --CO.sub.2 R.sup.6 ;
- Z.sup.3 is
- R is selected from:
- (1) C.sub.1-10 alkyl,
- (2) phenyl substituted with X and Y,
- (3) C.sub.1-10 alkyl substituted with phenyl, wherein the phenyl is substituted with X and Y, and
- (4) heteroaryl substituted with X and Y;
- R.sup.6 is independently selected at each occurrence from the group consisting of:
- (1) C.sub.1-20 alkyl;
- (2) substituted C.sub.1-20 alkyl in which one or more substituents is selected from the group X.sup.3, defined above,
- (3) C.sub.1-20 alkyl wherein one or more of the carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n --;
- (4) substituted C.sub.1-20 alkyl wherein one or more of the carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n -- and wherein one or more carbon substituents is selected from the group X.sup.3, defined above;
- (5) C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds;
- (6) substituted C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (7) C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and one or more of the nonolefinic carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n --;
- (8) substituted C.sub.2-20 alkenyl wherein alkenyl contains one or more double bonds and one or more of the nonolefinic carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n -- and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (9) C.sub.2-20 alkynyl wherein alkynyl contains one or more triple bonds;
- (10) substituted C.sub.2-20 alkynyl wherein alkynyl contains one or more triple bonds and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (11) C.sub.2-20 alkynyl wherein alkynyl contains one or more triple bonds and one or more of the saturated carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n --;
- (12) substituted C.sub.2-20 alkynyl wherein alkynyl contains one or more --triple bonds-- and one or more of the saturated carbons is replaced by --NR.sup.3 --, --O--, or --S(O).sub.n -- and wherein one or more of the saturated carbons is substituted with a substituent selected from the group X.sup.3, defined above;
- (13) aryl substituted with X and Y;
- (14) heteroaryl substituted with X and Y;
- (15) C.sub.3-5 cycloalkyl;
- (16) substituted C.sub.3-5 cycloakyl in which one or more of the substituents is selected from:
- (a) R.sup.3 O--, and
- (b) R.sup.3 R.sup.3 N--;
- and
- (17) hydrogen;
- aryl including X, Y substitution is:
- ##STR11## heteroaryl including X, Y substitution is selected from ##STR12## wherein:
- Q is --NR.sup.3, --O-- or --S--;
- heterocycloalkyl is selected from:
- ##STR13## wherein:
- M is --NR.sup.3, --O--, --S-- or --CH.sub.2 --;
- X and Y are each independently selected from:
- (1) hydrogen;
- (2) hydroxy;
- (3) halogen;
- (4) trifluoromethyl;
- (5) C.sub.1-10 alkyl;
- (6) aryl substituted with X.sup.1 and Y.sup.1 ;
- (7) R.sup.2 O--;
- (8) arylcarbonyloxy--, wherein aryl is substituted with X.sup.1 and Y.sup.1 ;
- (9) R.sup.3 --C(O)--O--;
- (10) --CO.sub.2 R.sup.2 ;
- (11) --CO.sub.2 H;
- and
- (12) nitro;
- and
- X.sup.1 and Y.sup.1 are each independently selected from:
- (1) hydrogen;
- (2) hydroxy;
- (3) halogen;
- (4) trifluoromethyl;
- (5) C.sub.1-4 alkyl;
- (6) R.sup.2 O--;
- (7) R.sup.3 --C(O)--O--;
- (8) --CO.sub.2 R.sup.2 ;
- (9) --CO.sub.2 H;
- and
- (10 ) nitro;
- or the pharmaceutically acceptable salt thereof.
147 more elements
Dependencies are inferred from the claim text.